| Todd Michael Saldinger, MD | |
|
2425 Samaritan Drive, San Jose, CA 95124 | |
| (408) 559-2011 | |
| Not Available |
| Full Name | Todd Michael Saldinger |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2425 Samaritan Drive, San Jose, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215975412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A66162 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Todd Michael Saldinger, MD 2100 Powell Street, Ste 920, Emeryville, CA 94608-1803 Ph: (510) 350-2777 | Todd Michael Saldinger, MD 2425 Samaritan Drive, San Jose, CA 95124 Ph: (408) 559-2011 |
News Archive
A. Alfred Taubman has become U-M's largest individual donor, with total giving of more than $142 million. His latest gift of $56 million to the A. Alfred Taubman Medical Research Institute, announced today before the University's Board of Regents, will bring his support of innovative medical science at the University of Michigan to a total of $100 million.
As levels of ozone and fine particulate pollution (PM2.5) rise, more patients end up in the ER with breathing problems, according to the largest U.S. study of air pollution and respiratory emergency room visits of patients of all ages.
A simple laboratory test may provide a new way for doctors to identify patients at risk of developing potentially severe acute kidney injury (AKI) after surgery up to three days before the problem would otherwise be detected, reports a pilot study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.
Improving health and economic costs after road traffic injuries is the focus of a new University of Queensland-led Centre of Research Excellence awarded $2.5 million by the National Health and Medical Research Council.
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 2 days ago
Anna Nguyen, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2105 Forest Ave, San Jose, CA 95128 Phone: 408-947-2500 | |
Shalin Hira Patel, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 225 N Jackson Ave, San Jose, CA 95116 Phone: 408-923-7121 | |
Tony Hue-dan Yuan, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 North Jackson Avenue, San Jose, CA 94608 Phone: 510-350-2777 | |
Rhys Vincent Dapar, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2425 Samaritan Drive, San Jose, CA 95124 Phone: 408-559-2011 | |
Xiao Wang, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Pkwy, San Jose, CA 95119 Phone: 408-362-4740 | |
Thomas Gildea, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2105 Forest Ave, San Jose, CA 95128 Phone: 408-947-2500 | |
Jacob Benford, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 North Jackson Avenue, San Jose, CA 95116 Phone: 408-923-7121 |